Florida Society of Clinical Oncology: The Voice of Oncology in Florida

Marketing Market Access Sales Clinical Liaisons Medical Affairs Government Affairs

W ho Should

Attend?

FLASCO Business of Oncology Summit

with The Spring Session & Annual Meeting

Healthcare Professionals:

Social Workers Financial

Counselors Patient Advocates

Oncologists Hematologists Advanced Practice Providers Oncology Nurses Practice Administrators

April 3-4, 2020

Industry Professionals:

Gaylord Palms Resort & Convention Center 6000 West Osceola Parkway, Kissimmee, FL 34746

www.FLASCO.org CLICK HERE TO REGISTER!

2020 Business of Oncology Meeting Agenda│April 3, 2020

KEYNOTE SPEAKERS Impactful Leaders from National Oncology Associations

Gain insight as we explore Barriers to Access at the 2020 Business of Oncology Summit. We will be joined by leaders from ASCO, ASH, COA, NCCN, and ACCC each discussing their organization’s perspectives on key strategies for the future of cancer care. Grow your knowledge of patient barriers to access for quality care, and identify potential opportunities to remove these barriers. Gain an understanding of local and national evolution in initiatives to maintain quality care for cancer patients as we review the role that different stakeholders play in resolving patient barriers to accessing quality cancer care.

The Vision for Cancer Care

Clifford Hudis, MD CEO

American Society of Clinical Oncology

Christian Downs, MHA, JD Executive Director

Association of Community Cancer Centers

Ted Okon, MBA Executive Director

Community Oncology Alliance

THE FLASCO CONFERENCE GOAL is to continue to develop a comprehensive range of programs that emphasize the latest developments, healthcare policy, state-of-the-art information and enhanced educational strategies for the interprofessional team.

CONFERENCE OUTCOME MEASURES: Participants should be able to apply the knowledge acquired during this conference to improve their competence, performance, and/or patient outcomes in the daily treatment of their patients. To measure attendees perceptions of these gains, they will complete an evaluation form after the conference.

Business of Oncology Summit│April 3, 2020

Time Session Panel Participants 8:15-8:30am

Introduction Thomas Marsland, MD and Denise Pierce

8:30-10:15am

The Vision for Cancer Care (Keynote Panel Presentation)

Moderator: Michael Kolodziej, MD, ADVI Health Panel Members: Alyssa Schatz, MSW, NCCN Clifford Hudis, MD, CEO, ASCO Christian Downs, MHA, JD: ACCC Ted Okon, MBA, COA Kathleen Hewitt, DNP, RN, CPHQ , ASH RC Data Hub

Break (10:15-10:30am)

10:30-11:30am

Paying for Care: Evolving

Value-Based Payer Initiatives

Moderator: Bo Gamble, COA Panel Members: Joseph Bailey, Cigna Scott McClelland, PharmD, Florida Blue Rogelio (Roger) Brito, MD, Aetna Andrew Hertler, MD, New Century Health

11:30am-12:15pm

Legislative/Regulatory

Insights

Moderator: Michael Diaz, MD, Florida Cancer Specialists Panel Members: Marc Samuels, ADVI Health Pareshkumar Patel, MD, FLASCO Legislative Committee Chairman Deborah Kamin, ASCO

Lunch (12:15-1:15pm)

1:15-2:15pm

Medicare Advantage and Patient Access

to Care: a grow-ing dilemma

Moderator: Denise K. Pierce, DK Pierce & Associates Panel Members: Clara Lambert, BBA, OPN-CG, ACCC Financial Advocacy Network Christy Banach, Florida Cancer Specialists Dan Sherman, Founder and President, The NaVectis Group Cancer Warrior– TBD

Break (2:15-2:30pm)

2:30-3:15pm

Social

Determinants of Health and

Implications for Cancer

Moderator: Thomas Marsland, MD– Program Chairman Panel Members: Wynn Sullivan, DO, Florida Cancer Specialists Anand Kuruvilla, MD, Cancer Center of Putnam Maray Salina, APRN, Memorial Healthcare System Speaker TBD

3:15-4:00pm

The Information Conundrum

Moderator: Merry Jennifer Markham, MD, UF Health Maen Hussein, MD, Florida Cancer Specialists Rick McDonough, MD, Florida Medical Clinic (Invited) Shelly Glenn, Florida Cancer Specialists Cancer Warrior –TBD Maggy Pons, CPA, MBA, Miami Cancer Institute

4:00-4:30pm

Closing State-ments and Q&A

Michael Kolodziej, MD and Denise K Pierce

REGISTER

HERE

2020 Spring Session Meeting Agenda│April 3-4, 2020

FLASCO Foundation Gala & Dorothy Green Phillips Retirement Celebration Join us for an exciting night of celebration and fundraising, as we honor Dorothy Green Phillips, Immediate Past Executive Director of FLASCO and celebrate her 20+ years of service to FLASCO and the Oncology Community! Celebrate with us as we raise funds for the FLASCO Foundation and present the 1st Annual “Dorothy Green Phillips Legacy Award” to an honorable FLASCO Member. Attendees will also enjoy great entertainment with a DJ, Hors d'oeuvres, Dancing, Networking and plenty of fun and good memories!

Friday, April 3, 2020

4:30pm - 6:00pm FLASCO Board of Director Event - Diamond Corporate Members Non CME/CE Open to All - Poster Presentation Come hear new and exciting research presentations

6:00pm – 7:30pm Visit Exhibits (Cash Bar Available)

7:30pm - 10:00pm FLASCO Foundation Gala

FLASCO Foundation Fundraiser and Dorothy Green Phillips Retirement Celebration

Saturday, April 4, 2020

7:00am - 8:00am Breakfast/Visit Exhibits

8:00am - 8:30am

Welcome, Awards, and Recognition of Service and Support Luis Raez, MD, FLASCO President

Spring Session Scientific Discussions Eric Harris, MD, FLASCO Program Committee Chairman

8:30am - 10:00am

A Panel Discussion on

Prostate Cancer: What’s New

Moderator: Winston Tan, MD, FACP, Mayo Clinic Florida Panel Members: Pathology: Jasreman Dhillon, MD, Moffitt Cancer Center Radiology: Manoj Jain, MD, Mayo Clinic Florida Radiation: Nancy Mendenhall, MD, UF Health Proton Therapy Institute Medical: Winston Tan, MD, FACP, Mayo Clinic Florida Case Study: Rohit Bishnoi, MD, University of Florida Hem/Onc Fellow

10:00am - 10:45am Break/Visit Exhibits

10:45am - 11:30am

An Update on Cancer-Related

Venous Thromboembolism

Moderator: Jose Sandoval-Sus, MD, Moffitt Cancer Center Malignant Hematology & Cellular Therapy at Memorial Healthcare System Speaker: Michael Jaglal, MD, MS, Moffitt Cancer Center Case Study: Ruchi Desai, MD, Moffitt Cancer Center

11:30am - 12:15pm Biosimilars Moderator: Christine Gegeckas, RPh, BCOP, FFSHP, Lee Health Speaker: Jorge Garcia, PharmD, Baptist Miami

Lung Cancer Series Working Lunch Open to all 12:30pm - 2:00pm

FLASCO Board Event - Diamond Elite Corporate Member Meetings Non CME/CE

2:00pm - 4:00pm Board of Directors Meeting Non CME/CE

Advanced Ticket Purchase Required!

$75/Person $125/Couple

Friday, April 3, 2020

2019-2020 FLASCO Leadership

OFFICERS

Luis E. Raez, MD President

Winston Tan, MD Vice President

Edgardo Santos, MD, FACP Secretary

Maen Hussein MD Treasurer

Rick McDonough, MD Immediate Past President

BOARD MEMBERS Syed Abid, MD Sikander Ailawadhi, MD Barry Berman, MD Simon Blanc, MD Christopher Bryant, MD Chakra Chaulagain, MD, FACP Craig Deligdish, MD Dina Dumercy, PharmD, BCOP Steven Fein, MD Karen Fields, MD Laura Freedman, MD Jorge J. Garcia, PharmD, MHA Faithlore Gardner, MD Thomas George, MD, FACP Lucio Gordan, MD Ardeshir Hakam, MD, MBA William Harrer, MD Eric Harris, DO Nalini Hasija, MD

Mohammad Jahanzeb, MD Kun Jiang, MD, PhD Sachin Kamath, MD Waseem Khan, MD Loretta Loftus, MD, MBA Reshma Mahtani, DO Yan Makeyev, MD Tarek Mekhail, MD, MSc, FRCSI Joseph Mignone, MD Mehdi Moezi, MD Anay Moscu, PharmD Zeina Nahleh, MD, FACP Pareshkumar Patel, MD Brendan Prendergast, MD Joseph Rosenblatt, MD Jose Sandoval-Sus, MD Shalin Shah, DO Jason Starr, DO Scott Tetreault, MD Jonathan Zager, MD

Florida Society of Clinical Oncology: The Voice of Oncology in Florida

Accreditation and Credit Statements

In support of improving patient care, this activity has been planned and implemented by the Medical Educator Consortium and the Florida Society of Medical Oncology. The Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Ed-ucation (ACCME), the Accreditation Council for Pharma-cy Education (ACPE), and the American Nurses Creden-tialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physician - The Medical Educator Consortium designates this live activity for a maximum of

9.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the cred-it commensurate with the extent of their participation in the activity. Nursing - The Medical Educator Consortium designates this activity for 9.5 contact hours. Pharmacotherapy contact hours for Advance Practice Regis-tered Nurses will be designated on your certificate.

Pharmacist - This Application based activity has been approved for 9.5 contact hours (.9 CEUs) by the Medical Educator Consortium. The Universal Activity Number for this program is JA4008179-9999-19-020-L01-P. Your CE credits will be electronically submitted to CPE Monitor® within 60 days upon successful completion of the activity. Physician Assistant -The Medical Educator Consortium has been authorized by the Ameri-

can Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 9.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Disclosure Policy - The Medical Educator Consortium (MEC) adheres to the Joint Accredi-tation Criteria and ACCME Standards for Commercial Support, which requires everyone in a position of controlling the content of a CME/CE activity to disclose all relevant financial rela-tionships with commercial interests related to the activity content. MEC has implemented a mechanism to identify and resolve all conflicts of interest prior to the CME/CE activity being delivered to learners. The source of all support from commercial interests will also be dis-closed to learners prior to the beginning of the educational activity. CME/CE activities must be balanced, independent of commercial bias, and designed to improve quality in health care. All recommendations involving clinical medicine must be based on evidence within the medi-cal profession. Disclosure of Unlabeled Use - This educational activity may contain discussion of pub-lished and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contradictions, and warnings.

Disclaimer - Participants have an implied responsibility to use the newly acquired infor-

mation to enhance patient outcomes and their own professional development. The information

presented in this activity is not meant to serve as a guideline for patient management. Any pro-

cedures, medications, or other courses of diagnosis or treatment discussed or suggested in this

activity should not be used by clinicians without evaluation of their patient’s conditions and

possible contradictions and/or dangers in use, review of any applicable manufacturer’s product

information, and comparison with recommendations of other authorities.

Registration Fees for Industry Professionals

To make RESERVATIONS please call 877-382-7299 or follow this link.

Be sure to mention FLASCO’s code word: FLASCO Spring Meetings for the discounted meeting rate of $212 (plus applicable taxes and hotel fees) per night. The hotel has requested that all reservations be made prior to RESERVATION DEADLINE: March 4, 2020. After that date, reservations will only be accepted on a space and rate available basis.

Page 4 of 4 REGISTRATION FEES & INFORMATION Business Of Oncology & Spring Session

Registration Fees for FLASCO Members (Non-Industry) Complimentary prior to March 4, 2020 for FLASCO Regular, Affiliate and Associate Members.

Membership Level Spring Session Fees Business Of Oncology Fees

Before March 4, 2020 After March 4, 2020 Before March 4, 2020 After March 4, 2020

FLASCO Regular Members Complimentary $50.00 Complimentary $50.00

FLASCO Affiliate Members Complimentary $50.00 Complimentary $50.00

FLASCO Associate Members Complimentary $50.00 Complimentary $50.00

FLASCO Courtesy Members $200.00 $250.00 $800 $850

Non-FLASCO Members $250.00 $300.00 $800 $850

*FLASCO reserves the right to alter this program without prior notice. Speakers and agenda are subject to change. www. FLASCO.org

A block of rooms has been reserved at the

Gaylord Palms Resort & Convention Center 6000 West Osceola Parkway, Kissimmee, FL

Reminder: To keep your complimentary membership active and in good standing, FLASCO members are encouraged to participate in at least one FLASCO event prior to December 31, 2021.

*All Corporate Members and Exhibitors are welcome to attend breakfast Saturday with advanced registration.

Industry Attendee Business of Oncology

Registration Fee Spring Exhibiting Fee

Diamond Elite Corporate Members: 1 Complimentary Attendee & $500/ Per Person

No Exhibit Fee for (3) 6’exhibit tables & (5) reps

Diamond Corporate Members: $600/ Per Person No Exhibit Fee for (2) 6’exhibit table & (4) reps

Platinum Corporate Members: $700/ Per Person No Exhibit Fee for (1) 6’ exhibit table & (3) reps

Gold Corporate Members: $750/ Per Person $500 Exhibit Fee for (1) 6’ table & (2) reps

Industry Attendee (Non-Corporate Member): $850/ Per Person

Exhibitor (Non– Corporate Member): There are no exhibits during the Business of Oncology Summit.

$2,000 Exhibit Fee for (1) 6’ table & (2) reps

HOTEL RESERVATIONS